Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CencoraWBO:ABC +1.95%72 Shiller PE Ratio is 56.92 as of Aug. 27, 2026, which is 3% below its 10-year median of 58.56. GuruFocus rates WBO:ABC with a GF Score™ of 72/100 and a GF Value™ of €260.71 (Fairly Valued). The stock has 2 warning signs investors should review. Among 69 Medical Distribution companies, Cencora ranks worse than 89.86% on this metric.
As of today (2026-08-27), Cencora's current share price is €282.30. Cencora's E10 for the quarter that ended in Jun. 2026 was €4.96. Cencora's Shiller PE Ratio for today is 56.92.
The historical rank and industry rank for Cencora's Shiller PE Ratio or its related term are showing as below:
WBO:ABC'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 22.59 Med: 58.56 Max: 85.42
Current: 57.4
During the past years, Cencora's highest Shiller PE Ratio was 85.42. The lowest was 22.59. And the median was 58.56.
WBO:ABC's Shiller PE Ratio is ranked worse than 89.86% of 69
companies
in the Medical Distribution industry
Industry Median: 15.62
vs WBO:ABC: 57.40
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
Cencora's adjusted earnings per share data for the three months ended in Jun. 2026 was €3.420. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €4.96 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
Cencora Shiller PE Ratio Related Terms
Cencora Shiller PE Ratio Historical Data
* Premium members only.
The historical data trend for Cencora's Shiller PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:ABC vs CAH, MCK, HSIC: Shiller PE Ratio Comparison
For the Medical Distribution subindustry, Cencora's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cencora Shiller PE Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cencora's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where Cencora's Shiller PE Ratio falls into.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
Cencora's Shiller PE Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cencora's E10 for the quarter that ended in Jun. 2026 is calculated as:
For example, Cencora's adjusted earnings per share data for the three months ended in Jun. 2026 was:
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Cencora (WBO:ABC) has a Shiller PE Ratio of 56.92 as of Aug. 27, 2026. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Cencora and its competitors. This is near median its historical median of 58.56. Over the past decade, Cencora's Shiller PE Ratio has ranged from 22.59 to 85.42. According to the industry distribution chart, Cencora ranks #62 out of 69 companies in the Medical Distribution industry, placing it in the top 89.9%.
Is Cencora's Shiller PE Ratio too high?
Cencora's current Shiller PE Ratio of 56.92 is near median its 10-year median of 58.56. Over the past 10 years, this metric has ranged from a low of 22.59 to a high of 85.42. The Medical Distribution industry median Shiller PE Ratio is 15.62. Cencora's value of 56.92 is 264.4% above this industry median. Based on the distribution chart, Cencora ranks #62 out of 69 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Cencora has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Shiller PE Ratio compare to CAH and MCK?
According to the Medical Distribution industry distribution chart, Cencora ranks #62 out of 69 companies for Shiller PE Ratio. This places Cencora in the lower half of its industry. The industry median Shiller PE Ratio is 15.62. Cencora's value of 56.92 is 264.4% above this benchmark. Historically, Cencora's own Shiller PE Ratio has ranged from 22.59 to 85.42 over the past decade. While the company's 10-year median is 58.56 vs. the industry median of 15.62, Cencora has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shiller PE Ratio for a Medical Distribution company?
The median Shiller PE Ratio among Medical Distribution companies is 15.62, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a Shiller PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Shiller PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cencora's current Shiller PE Ratio of 56.92 is 264.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shiller PE Ratio mean?
A high Shiller PE Ratio can signal that a stock is expensive relative to its fundamentals. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Cencora and its competitors. For the Medical Distribution industry, the median Shiller PE Ratio is 15.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cencora's current Shiller PE Ratio is 56.92, which is near median its own 10-year median of 58.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (WBO:ABC) is currently considered Fairly Valued. The stock's GF Value™ is €260.71, compared to a current price of €282.30 — trading 8.3% above its estimated fair value. The current Shiller PE Ratio is 56.92, which is near median its 10-year median of 58.56 and 264.4% above the Medical Distribution industry median of 15.62. Cencora's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shiller PE Ratio calculated?
Shiller PE Ratio is calculated from a company's financial statements. For Cencora (WBO:ABC), the current Shiller PE Ratio is 56.92 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cencora (WBO:ABC) Overvalued in 2026?
Based on GuruFocus' analysis, Cencora stock appears to be overvalued.
The current stock price of €282.30 is trading 8.3% above its estimated GF Value™ of €260.71.
GuruFocus considers Cencora to be Fairly Valued.
Key valuation signals for WBO:ABC:
Shiller PE Ratio: 56.92 (near median its 10-year median of 58.56)
GF Value™: €260.71 vs. price of €282.30 (8.3% above fair value)
Industry Position: 264.4% above the Medical Distribution median (#62 of 69)
No single metric tells the full story. See the WBO:ABC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
72GF Score
Get the complete analysis for WBO:ABC
Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ABC has been successfully added to your 
